Irritable bowel syndrome natural history, complications and prognosis: Difference between revisions
Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3]. | If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].<ref name="pmid15080847">{{cite journal |vauthors=El-Serag HB, Pilgrim P, Schoenfeld P |title=Systemic review: Natural history of irritable bowel syndrome |journal=Aliment. Pharmacol. Ther. |volume=19 |issue=8 |pages=861–70 |year=2004 |pmid=15080847 |doi=10.1111/j.1365-2036.2004.01929.x |url=}}</ref><ref name="pmid22474441">{{cite journal |vauthors=Olafsdottir LB, Gudjonsson H, Jonsdottir HH, Björnsson E, Thjodleifsson B |title=Natural history of irritable bowel syndrome in women and dysmenorrhea: a 10-year follow-up study |journal=Gastroenterol Res Pract |volume=2012 |issue= |pages=534204 |year=2012 |pmid=22474441 |pmc=3312222 |doi=10.1155/2012/534204 |url=}}</ref> | ||
OR | OR | ||
Line 14: | Line 14: | ||
Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%. | Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%. | ||
==Natural History, Complications, and Prognosis== | ==Natural History, Complications, and Prognosis== |
Revision as of 20:17, 1 November 2017
Irritable bowel syndrome Microchapters |
Differentiating Irritable bowel syndrome from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Irritable bowel syndrome natural history, complications and prognosis On the Web |
American Roentgen Ray Society Images of Irritable bowel syndrome natural history, complications and prognosis |
FDA on Irritable bowel syndrome natural history, complications and prognosis |
CDC on Irritable bowel syndrome natural history, complications and prognosis |
Irritable bowel syndrome natural history, complications and prognosis in the news |
Blogs on Irritable bowel syndrome natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].[1][2]
OR
Common complications of [disease name] include [complication 1], [complication 2], and [complication 3].
OR
Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%.
Natural History, Complications, and Prognosis
Natural History
- The symptoms of (disease name) usually develop in the first/ second/ third decade of life, and start with symptoms such as ___.
- The symptoms of (disease name) typically develop ___ years after exposure to ___.
- If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
Complications
Complications of irritable bowel syndrome may include:
- Impacted bowel [4]
- Hemorrhoids [5][6]
- Depression and anxiety
- Fatigue [7]
- Discomfort[8]
- Malnutrition, resulting from food intolerance
- Common complications of [disease name] include:
- [Complication 1]
- [Complication 2]
- [Complication 3]
Prognosis
Irritable bowel syndrome may be a life-long condition, but symptoms can often be improved or relieved through treatment.
- Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%.
- Depending on the extent of the [tumor/disease progression/etc.] at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as poor/good/excellent.
- The presence of [characteristic of disease] is associated with a particularly [good/poor] prognosis among patients with [disease/malignancy].
- [Subtype of disease/malignancy] is associated with the most favorable prognosis.
- The prognosis varies with the [characteristic] of tumor; [subtype of disease/malignancy] have the most favorable prognosis.
References
- ↑ El-Serag HB, Pilgrim P, Schoenfeld P (2004). "Systemic review: Natural history of irritable bowel syndrome". Aliment. Pharmacol. Ther. 19 (8): 861–70. doi:10.1111/j.1365-2036.2004.01929.x. PMID 15080847.
- ↑ Olafsdottir LB, Gudjonsson H, Jonsdottir HH, Björnsson E, Thjodleifsson B (2012). "Natural history of irritable bowel syndrome in women and dysmenorrhea: a 10-year follow-up study". Gastroenterol Res Pract. 2012: 534204. doi:10.1155/2012/534204. PMC 3312222. PMID 22474441.
- ↑ Morley JE, Steinberg KE (2009). "Diarrhea in long-term care: a messy problem". J Am Med Dir Assoc. 10 (4): 213–7. doi:10.1016/j.jamda.2009.01.007. PMID 19426933.
- ↑ Mearin F, Ciriza C, Mínguez M, Rey E, Mascort JJ, Peña E, Cañones P, Júdez J (2016). "Clinical Practice Guideline: Irritable bowel syndrome with constipation and functional constipation in the adult". Rev Esp Enferm Dig. 108 (6): 332–63. doi:10.17235/reed.2016.4389/2016. PMID 27230827.
- ↑ Arora G, Mannalithara A, Mithal A, Triadafilopoulos G, Singh G (2012). "Concurrent conditions in patients with chronic constipation: a population-based study". PLoS ONE. 7 (10): e42910. doi:10.1371/journal.pone.0042910. PMC 3470567. PMID 23071488.
- ↑ Tan KY, Seow-Choen F (2007). "Fiber and colorectal diseases: separating fact from fiction". World J. Gastroenterol. 13 (31): 4161–7. PMC 4250613. PMID 17696243.
- ↑ Han CJ, Yang GS (2016). "Fatigue in Irritable Bowel Syndrome: A Systematic Review and Meta-analysis of Pooled Frequency and Severity of Fatigue". Asian Nurs Res (Korean Soc Nurs Sci). 10 (1): 1–10. doi:10.1016/j.anr.2016.01.003. PMID 27021828.
- ↑ Chakiath RJ, Siddall PJ, Kellow JE, Hush JM, Jones MP, Marcuzzi A, Wrigley PJ (2015). "Descending pain modulation in irritable bowel syndrome (IBS): a systematic review and meta-analysis". Syst Rev. 4: 175. doi:10.1186/s13643-015-0162-8. PMC 4674951. PMID 26652749.